Nomograms and prognosis for superficial esophageal squamous cell carcinoma
- PMID: 38596490
- PMCID: PMC11000082
- DOI: 10.3748/wjg.v30.i10.1291
Nomograms and prognosis for superficial esophageal squamous cell carcinoma
Abstract
In recent years, endoscopic resection, particularly endoscopic submucosal dissection, has become increasingly popular in treating non-metastatic superficial esophageal squamous cell carcinoma (ESCC). In this evolving paradigm, it is crucial to identify factors that predict higher rates of lymphatic invasion and poorer outcomes. Larger tumor size, deeper invasion, poorer differentiation, more infiltrative growth patterns (INF-c), higher-grade tumor budding, positive lymphovascular invasion, and certain biomarkers have been associated with lymph node metastasis and increased morbidity through retrospective reviews, leading to the construction of comprehensive nomograms for outcome prediction. If validated by future prospective studies, these nomograms would prove highly applicable in guiding the selection of treatment for superficial ESCC.
Keywords: Endoscopic mucosal resection; Endoscopic submucosal dissection; Esophageal cancer; Esophageal resection; Esophageal squamous cell carcinoma; Lymph node metastasis.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: None of the authors have any relevant conflicts to disclose.
Similar articles
-
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma.World J Gastroenterol. 2023 Dec 21;29(47):6138-6147. doi: 10.3748/wjg.v29.i47.6138. World J Gastroenterol. 2023. PMID: 38186680 Free PMC article.
-
Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.J Gastroenterol. 2019 Oct;54(10):871-880. doi: 10.1007/s00535-019-01583-9. Epub 2019 May 4. J Gastroenterol. 2019. PMID: 31055660
-
Correlation between tumor budding and the long-term follow-up outcomes after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.Surg Endosc. 2024 Oct;38(10):5575-5583. doi: 10.1007/s00464-024-11124-y. Epub 2024 Aug 1. Surg Endosc. 2024. PMID: 39090202
-
Feasibility of Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma with Relative Indications.Dig Surg. 2021;38(1):14-23. doi: 10.1159/000507437. Epub 2020 Dec 3. Dig Surg. 2021. PMID: 33271540 Review.
-
[Endoscopic Treatment for Esophageal Cancer].Korean J Gastroenterol. 2018 Mar 25;71(3):116-123. doi: 10.4166/kjg.2018.71.3.116. Korean J Gastroenterol. 2018. PMID: 29566472 Review. Korean.
Cited by
-
A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study.Front Immunol. 2025 Feb 14;16:1524439. doi: 10.3389/fimmu.2025.1524439. eCollection 2025. Front Immunol. 2025. PMID: 40028339 Free PMC article.
-
The Clinical Value of hsa_circ_0000419 in Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.Biochem Genet. 2025 Jul 15. doi: 10.1007/s10528-025-11194-0. Online ahead of print. Biochem Genet. 2025. PMID: 40663284
References
-
- Mukkamalla SKR, Recio-Boiles A, Babiker HM. Esophageal Cancer. 2023 Mar 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan- - PubMed
-
- Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022;163:649–658.e2. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical